닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Symons Julian]

113건 중 113건 출력

, 8/12 페이지

  • 71
    Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules
    Kao, C. Cheng; Nie, Yuchun; Ren, Suping; De Costa, N. Tilani T.S.; Pandey, Rajendra K.; Hong, Jin; Smith, David B.; Symons, Julian A.; Beigelman, Leonid; Blatt, Lawrence M.; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; Aligos Therapeutics, Inc., 1 Corporate Drive, South San Francisco, CA 94080, USA; (Molecular therapy. Nucleic acids, v.27, 2022, pp.335-348)
  • 72
    Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies
    Taylor, Joshua S.; Zhang, Qingling; Julander, Justin G.; Stoycheva, Antitsa D.; Tan, Hua; Moy, Christabel V.; Chanda, Sushmita; Symons, Julian A.; Beigelman, Leonid N.; Blatt, Lawrence M.; Hong, Jin; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Utah State University, Logan, Utah.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; Alios BioPharma, South San Francisco, California.; (Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, v.35, 2015, pp.621-633)
  • 73
    Molecular, cellular, and pharmacological characterization of beta-selective partial agonists of human thyroid hormone receptor for the treatment of non-alcoholic steatohepatitis
    Deval, Jerome; Stevens, Sarah; Luong, Xuan; Jekle, Andreas; Lin, Tse-I; Gupta, Kusum; Misner, Dinah; Chanda, Sushmita; Liu, Jyanwei; Williams, Caroline; Stoycheva, Antitsa; Beigelman, Leonid; Symons, Julian; Raboisson, Pierre; Vandyck, Koen; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.73, 2020, pp.S448-S449)
  • 74
    Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479
    Ali, Samir; Leveque, Vincent; Le Pogam, Sophie; Ma, Han; Philipp, Friederike; Inocencio, Nicole; Smith, Mark; Alker, Andre; Kang, Hyunsoon; Najera, Isabel; Klumpp, Klaus; Symons, Julian; Cammack, Nick; Jiang, Wen-Rong; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Hoffman-La Roche, Basel, Switzerland; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; Roche Palo Alto LLC, Palo Alto, California; (Antimicrobial agents and chemotherapy, v.52, 2008, pp.4356-4369)
  • 75
    Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase
    Deval, Jerome; Fung, Amy; Stevens, Sarah K.; Jordan, Paul C.; Gromova, Tatiana; Taylor, Joshua S.; Hong, Jin; Meng, Jia; Wang, Guangyi; Dyatkina, Natalia; Prhavc, Marija; Symons, Julian A.; Beigelman, Leo; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, California, United States of America; Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, Califor; (PloS one, v.11, 2016, pp.e0154097)
  • 76
    Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial
    Myles, Paul S.; Richards, Toby; Klein, Andrew; Smith, Julian; Wood, Erica M.; Heritier, Stephane; McGiffin, David; Zavarsek, Silva; Symons, Joel; McQuilten, Zoe K.; Baker, Robert A.; Karkouti, Keyvan; Wallace, Sophia; Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital; Department of Anaesthesiology and Perioperative Medicine, Monash University; Department of Anaesthesiology and Perioperative Medicine, Monash University; Department of Cardiothoracic Surgery, Monash Health; Department of Clinical Haematology, Monash Health and University; School of Public Health and Preventive Medicine, Monash University; Department of Cardiothoracic Surgery, Alfred Hospital; Deakin Health Economics, Institute for Health Transformation, Faculty of Health, Deakin University; Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital; Department of Clinical Haematology, Monash Health and University Australia<; (The American heart journal, v.239, 2021, pp.64-72)
  • 77
    Selective inhibition of human β-catenin DNA transactivation activity using splice switching oligonucleotides for an improved therapeutic window in treating hepatocellular carcinoma
    Hong, Jin; Huang, Vera; Eltepu, Laxman; Tan, Hua; Rajwanshi, Vivek; Bhattacharya, Aneerban; Rosler, Elen; Hyunsoon, Kang; Luo, Min; Montero, Saul; Cortez, John; Cho, Dana; Smith, David; Blatt, Lawrence; Symons, Julian; Beigelman, Leonid; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.78, 2023, pp.S548-S549)
  • 78
    Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
    Liu, Cheng; Boland, Sandro; Scholle, Michael D.; Bardiot, Dorothee; Marchand, Arnaud; Chaltin, Patrick; Blatt, Lawrence M.; Beigelman, Leonid; Symons, Julian A.; Raboisson, Pierre; Gurard-Levin, Zachary A.; Vandyck, Koen; Deval, Jerome; Aligos Therapeutics, Inc.; Cistim; SAMDI Tech, Inc.; Cistim; Cistim; Cistim; Aligos Therapeutics, Inc.; Aligos Therapeutics, Inc.; Aligos Therapeutics, Inc.; Aligos Belgium BV; SAMDI Tech, Inc.; Aligos Belgium BV; Aligos Therapeutics, Inc.; (Antiviral research, v.187, 2021, pp.105020)
  • 79
    Preclinical pharmacokinetic, pharmacodynamic and efficacy relationships of ALG-093702, a liver targeted PD-L1 small molecule inhibitor, in different in vivo models
    Roose, Heleen; Zhang, Qingling; Le, Kha; Jekle, Andreas; Rekstyte-Matiene, Kristina; Stevens, Sarah; Jaisinghani, Ruchika; Liu, Cheng; Chang, Sandra; Stoycheva, Antitsa; Blatt, Lawrence; Beigelman, Leonid; Symons, Julian; Chanda, Sushmita; Gonzalvez, Francois; Wu, Tongfei; ; (Journal of hepatology : the journal of the European Association for the Study of the Liver, v.78, 2023, pp.S1030-S1031)
  • 80
    Safety and Pharmacokinetics of the Respiratory Syncytial Virus Polymerase Inhibitor, ALS-8176, in Otherwise Healthy Infants Hospitalized with Acute RSV Infection
    Finn, Adam; Fayon, Michael; Bernatoniene, Jolanta; Luciani, Kathia; Uppala, Rattapon; Fry, John; Chanda, Sushmita; Smith, Patrick; Nieforth, Keith; Patel, Kashyap; Oey, Abbie; Symons, Julian; Zhang, Qingling; Blatt, Lawrence; Beigelman, Leonid; Mcclure, Matthew; University of Bristol, Bristol, United Kingdom; CHU de Bordeaux, Bordeaux, France; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; Hospital de Especialidades Pediá tricas de la Caja de Seguro Social, Panamá , Panama; Khon Kaen University, Khon Kaen, Thailand; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; D3 Medicine, Parsippany, NJ; D3 Medicine, Parsippany, NJ; Monash University, Parkville, Australia; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; Alios BioPharma, South San Francisco, CA; (Open forum infectious diseases, v.3, 2016, pp.1349)

처음 오셨나요?